CN108684999A - A kind of motor function beverage - Google Patents
A kind of motor function beverage Download PDFInfo
- Publication number
- CN108684999A CN108684999A CN201810326525.2A CN201810326525A CN108684999A CN 108684999 A CN108684999 A CN 108684999A CN 201810326525 A CN201810326525 A CN 201810326525A CN 108684999 A CN108684999 A CN 108684999A
- Authority
- CN
- China
- Prior art keywords
- ingredient
- composition
- vitamin
- substance
- premix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 16
- 230000007659 motor function Effects 0.000 title claims abstract description 9
- 239000000126 substance Substances 0.000 claims abstract description 67
- 239000000203 mixture Substances 0.000 claims abstract description 63
- 229940024606 amino acid Drugs 0.000 claims abstract description 52
- 235000001014 amino acid Nutrition 0.000 claims abstract description 52
- 150000001413 amino acids Chemical class 0.000 claims abstract description 52
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 44
- 235000010755 mineral Nutrition 0.000 claims abstract description 44
- 239000011707 mineral Substances 0.000 claims abstract description 44
- 235000019742 Vitamins premix Nutrition 0.000 claims abstract description 33
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims abstract description 21
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims abstract description 21
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 20
- 235000013930 proline Nutrition 0.000 claims abstract description 20
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 19
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229960002429 proline Drugs 0.000 claims abstract description 19
- 239000004474 valine Substances 0.000 claims abstract description 19
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 17
- -1 composition first Chemical class 0.000 claims abstract description 15
- 239000011734 sodium Substances 0.000 claims abstract description 14
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 14
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 13
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims abstract description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 13
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 13
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000011575 calcium Substances 0.000 claims abstract description 13
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 13
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229960002591 hydroxyproline Drugs 0.000 claims abstract description 13
- 239000011777 magnesium Substances 0.000 claims abstract description 13
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 13
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 13
- 239000011669 selenium Substances 0.000 claims abstract description 13
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000011782 vitamin Substances 0.000 claims abstract description 13
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 12
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000470 constituent Substances 0.000 claims abstract description 12
- 239000011630 iodine Substances 0.000 claims abstract description 12
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 12
- 239000011591 potassium Substances 0.000 claims abstract description 12
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 12
- 229940088594 vitamin Drugs 0.000 claims abstract description 12
- 229930003231 vitamin Natural products 0.000 claims abstract description 12
- 235000013343 vitamin Nutrition 0.000 claims abstract description 12
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 11
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims abstract description 9
- 235000013922 glutamic acid Nutrition 0.000 claims abstract description 9
- 239000004220 glutamic acid Substances 0.000 claims abstract description 9
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims abstract description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 6
- 229960002989 glutamic acid Drugs 0.000 claims abstract description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 4
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 4
- 239000011719 vitamin A Substances 0.000 claims abstract description 4
- 229940045997 vitamin a Drugs 0.000 claims abstract description 4
- 239000004615 ingredient Substances 0.000 claims description 325
- 239000000843 powder Substances 0.000 claims description 78
- 230000006870 function Effects 0.000 claims description 48
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 38
- 108010046377 Whey Proteins Proteins 0.000 claims description 30
- 102000007544 Whey Proteins Human genes 0.000 claims description 30
- 150000005693 branched-chain amino acids Chemical class 0.000 claims description 27
- 239000002994 raw material Substances 0.000 claims description 27
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 26
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical group CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 26
- 239000005862 Whey Substances 0.000 claims description 25
- 108010068370 Glutens Proteins 0.000 claims description 24
- 241000209140 Triticum Species 0.000 claims description 24
- 235000021307 Triticum Nutrition 0.000 claims description 24
- 235000021312 gluten Nutrition 0.000 claims description 24
- 244000068988 Glycine max Species 0.000 claims description 22
- 235000010469 Glycine max Nutrition 0.000 claims description 22
- 101710089165 Protein white Proteins 0.000 claims description 22
- 238000000926 separation method Methods 0.000 claims description 22
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical group Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 21
- 238000002156 mixing Methods 0.000 claims description 20
- 102000008186 Collagen Human genes 0.000 claims description 19
- 108010035532 Collagen Proteins 0.000 claims description 19
- 229930003451 Vitamin B1 Natural products 0.000 claims description 19
- 229920001436 collagen Polymers 0.000 claims description 19
- 229960003080 taurine Drugs 0.000 claims description 19
- 229960003495 thiamine Drugs 0.000 claims description 19
- 235000010374 vitamin B1 Nutrition 0.000 claims description 19
- 239000011691 vitamin B1 Substances 0.000 claims description 19
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 18
- 239000000945 filler Substances 0.000 claims description 18
- 244000060011 Cocos nucifera Species 0.000 claims description 17
- VDTNNGKXZGSZIP-UHFFFAOYSA-N carbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 VDTNNGKXZGSZIP-UHFFFAOYSA-N 0.000 claims description 17
- 239000013078 crystal Substances 0.000 claims description 17
- 239000005913 Maltodextrin Substances 0.000 claims description 16
- 229920002774 Maltodextrin Polymers 0.000 claims description 16
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims description 16
- 229940035034 maltodextrin Drugs 0.000 claims description 16
- 235000008939 whole milk Nutrition 0.000 claims description 16
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 14
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 13
- 235000019158 vitamin B6 Nutrition 0.000 claims description 13
- 239000011726 vitamin B6 Substances 0.000 claims description 13
- 229940011671 vitamin b6 Drugs 0.000 claims description 13
- 229940091258 selenium supplement Drugs 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 11
- 229960003975 potassium Drugs 0.000 claims description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 10
- 230000003301 hydrolyzing effect Effects 0.000 claims description 10
- 150000004667 medium chain fatty acids Chemical class 0.000 claims description 10
- 239000004375 Dextrin Substances 0.000 claims description 9
- 229920001353 Dextrin Polymers 0.000 claims description 9
- 239000004376 Sucralose Substances 0.000 claims description 9
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 9
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 9
- 235000019425 dextrin Nutrition 0.000 claims description 9
- 239000002002 slurry Substances 0.000 claims description 9
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 9
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 9
- 235000019408 sucralose Nutrition 0.000 claims description 9
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical group OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 8
- 235000020733 paullinia cupana extract Nutrition 0.000 claims description 8
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 7
- 229920001100 Polydextrose Polymers 0.000 claims description 7
- 239000000905 isomalt Substances 0.000 claims description 7
- 235000010439 isomalt Nutrition 0.000 claims description 7
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 7
- 239000001259 polydextrose Substances 0.000 claims description 7
- 235000013856 polydextrose Nutrition 0.000 claims description 7
- 229940035035 polydextrose Drugs 0.000 claims description 7
- 229940026510 theanine Drugs 0.000 claims description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 6
- 229960002477 riboflavin Drugs 0.000 claims description 6
- 229910021529 ammonia Inorganic materials 0.000 claims description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 4
- 229930003471 Vitamin B2 Natural products 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 4
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 4
- 235000019164 vitamin B2 Nutrition 0.000 claims description 4
- 239000011716 vitamin B2 Substances 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 claims description 3
- 229930091371 Fructose Natural products 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- 108010073771 Soybean Proteins Proteins 0.000 claims description 3
- 229930003779 Vitamin B12 Natural products 0.000 claims description 3
- 229930003316 Vitamin D Natural products 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical group [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 3
- 235000015177 dried meat Nutrition 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 235000019710 soybean protein Nutrition 0.000 claims description 3
- 235000019163 vitamin B12 Nutrition 0.000 claims description 3
- 239000011715 vitamin B12 Substances 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 3
- 239000011710 vitamin D Substances 0.000 claims description 3
- 150000003710 vitamin D derivatives Chemical group 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940046008 vitamin d Drugs 0.000 claims description 3
- 235000000638 D-biotin Nutrition 0.000 claims description 2
- 239000011665 D-biotin Substances 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 2
- 239000011666 cyanocobalamin Substances 0.000 claims description 2
- 229960002104 cyanocobalamin Drugs 0.000 claims description 2
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 2
- 239000011706 ferric diphosphate Substances 0.000 claims description 2
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 2
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 2
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 2
- 239000001095 magnesium carbonate Substances 0.000 claims description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 2
- 125000000627 niacin group Chemical group 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- 125000003201 pantothenic acid group Chemical group 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- 239000001508 potassium citrate Substances 0.000 claims description 2
- 229960002635 potassium citrate Drugs 0.000 claims description 2
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 2
- 235000011082 potassium citrates Nutrition 0.000 claims description 2
- 235000019192 riboflavin Nutrition 0.000 claims description 2
- 239000002151 riboflavin Substances 0.000 claims description 2
- 239000001509 sodium citrate Substances 0.000 claims description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 2
- 239000011781 sodium selenite Substances 0.000 claims description 2
- 229960001471 sodium selenite Drugs 0.000 claims description 2
- 235000015921 sodium selenite Nutrition 0.000 claims description 2
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 2
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 2
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 2
- 229960001763 zinc sulfate Drugs 0.000 claims description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 2
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 claims 1
- 241000737241 Cocos Species 0.000 claims 1
- 235000000556 Paullinia cupana Nutrition 0.000 claims 1
- 240000003444 Paullinia cupana Species 0.000 claims 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 abstract description 12
- 239000013589 supplement Substances 0.000 abstract description 8
- 230000033001 locomotion Effects 0.000 description 39
- 239000000047 product Substances 0.000 description 25
- 102000004420 Creatine Kinase Human genes 0.000 description 21
- 108010042126 Creatine kinase Proteins 0.000 description 21
- 238000010586 diagram Methods 0.000 description 18
- 235000013616 tea Nutrition 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 229960004295 valine Drugs 0.000 description 15
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 14
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 14
- 239000003094 microcapsule Substances 0.000 description 13
- 210000003205 muscle Anatomy 0.000 description 13
- 230000009183 running Effects 0.000 description 11
- 238000013461 design Methods 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 230000006378 damage Effects 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 229960000890 hydrocortisone Drugs 0.000 description 7
- 229960003604 testosterone Drugs 0.000 description 7
- 229930003761 Vitamin B9 Natural products 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- 229960000310 isoleucine Drugs 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 239000011573 trace mineral Substances 0.000 description 6
- 235000013619 trace mineral Nutrition 0.000 description 6
- 235000019159 vitamin B9 Nutrition 0.000 description 6
- 239000011727 vitamin B9 Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 229910001385 heavy metal Inorganic materials 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 5
- 229960003136 leucine Drugs 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 235000021119 whey protein Nutrition 0.000 description 5
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 4
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 4
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 4
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 229910052793 cadmium Inorganic materials 0.000 description 4
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 4
- 239000010941 cobalt Substances 0.000 description 4
- 229910017052 cobalt Inorganic materials 0.000 description 4
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 4
- 229960004544 cortisone Drugs 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 4
- 229910052753 mercury Inorganic materials 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 235000019175 phylloquinone Nutrition 0.000 description 4
- 239000011772 phylloquinone Substances 0.000 description 4
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 4
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 4
- 229960001898 phytomenadione Drugs 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012827 research and development Methods 0.000 description 4
- 239000004576 sand Substances 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- 229910052712 strontium Inorganic materials 0.000 description 4
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 description 3
- KLYCPFXDDDMZNQ-UHFFFAOYSA-N Benzyne Chemical compound C1=CC#CC=C1 KLYCPFXDDDMZNQ-UHFFFAOYSA-N 0.000 description 3
- 101710088194 Dehydrogenase Proteins 0.000 description 3
- 239000004606 Fillers/Extenders Substances 0.000 description 3
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 3
- 208000029549 Muscle injury Diseases 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 3
- 208000002894 beriberi Diseases 0.000 description 3
- 230000023852 carbohydrate metabolic process Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000003054 hormonal effect Effects 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 239000011572 manganese Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 2
- VVJYUAYZJAKGRQ-UHFFFAOYSA-N 1-[4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C(O)C1 VVJYUAYZJAKGRQ-UHFFFAOYSA-N 0.000 description 2
- WHBHBVVOGNECLV-UHFFFAOYSA-N 11-deoxy-17-hydroxy-corticosterone Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 WHBHBVVOGNECLV-UHFFFAOYSA-N 0.000 description 2
- ZESRJSPZRDMNHY-YFWFAHHUSA-N 11-deoxycorticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 ZESRJSPZRDMNHY-YFWFAHHUSA-N 0.000 description 2
- WHBHBVVOGNECLV-OBQKJFGGSA-N 11-deoxycortisol Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 WHBHBVVOGNECLV-OBQKJFGGSA-N 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 2
- DBPWSSGDRRHUNT-CEGNMAFCSA-N 17α-hydroxyprogesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2 DBPWSSGDRRHUNT-CEGNMAFCSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 2
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 229960002478 aldosterone Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229960003473 androstanolone Drugs 0.000 description 2
- 229910052785 arsenic Inorganic materials 0.000 description 2
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229960002433 cysteine Drugs 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- ZESRJSPZRDMNHY-UHFFFAOYSA-N de-oxy corticosterone Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 ZESRJSPZRDMNHY-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 229960003399 estrone Drugs 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 125000003929 folic acid group Chemical group 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229960003104 ornithine Drugs 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229940043230 sarcosine Drugs 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- DATAGRPVKZEWHA-UHFFFAOYSA-N L-gamma-glutamyl-n-ethylamine Natural products CCNC(=O)CCC(N)C(O)=O DATAGRPVKZEWHA-UHFFFAOYSA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- CZWCKYRVOZZJNM-UHFFFAOYSA-N Prasterone sodium sulfate Natural products C1C(OS(O)(=O)=O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 CZWCKYRVOZZJNM-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000005550 amino acid supplement Nutrition 0.000 description 1
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 description 1
- 229960005471 androstenedione Drugs 0.000 description 1
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002719 buserelin Drugs 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 101150024923 da gene Proteins 0.000 description 1
- CZWCKYRVOZZJNM-USOAJAOKSA-N dehydroepiandrosterone sulfate Chemical compound C1[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 CZWCKYRVOZZJNM-USOAJAOKSA-N 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 229950006137 dexfosfoserine Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- ZNOVTXRBGFNYRX-ABLWVSNPSA-N levomefolic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 ZNOVTXRBGFNYRX-ABLWVSNPSA-N 0.000 description 1
- 235000007635 levomefolic acid Nutrition 0.000 description 1
- 239000011578 levomefolic acid Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 229950009829 prasterone sulfate Drugs 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 235000014268 sports nutrition Nutrition 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pediatric Medicine (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of motor function beverages.The present invention provides a kind of compositions for providing amino acid, vitamin and mineral, including composition first, composition second and composition third;Composition first is the composition for providing amino acid, including following 7 kinds of active ingredient:Hydroxyproline, proline, glutamic acid, Amino Acids in Tea, L-Leu, l-Isoleucine and Valine;Composition second is vitamin premix, including providing the substance of following 12 kinds of active ingredient:Vitamin A, B1, B2, B3, B5, B6, B9, B12, C, D, E, H;Composition third is mineral substance premix, including providing the substance of following 9 kinds of active ingredient:Sodium element, P elements, potassium element, magnesium elements, calcium constituent, ferro element, Zn-ef ficiency, selenium element, iodine.The present invention is based on multigroup data, and integrally the element that supplements the nutrients comprehensively, has filled up the blank of the domestic accurate nutrient of limit endurance race.
Description
Technical field
The present invention relates to a kind of motor function beverages.
Background technology
There are all kinds of vitamin replenishers, sports drink also to have more reinforcing B family vitamin and vitamin C on the market at present,
But it is confined to a certain or a or two kind of combination mostly, the multivitamin based on Chinese population data basis and minerals collaboration
Intervention products almost blank.For the prior art because functional component is single, effect is poor, and without being transported for high intensity endurance
The accurate nutritional supplement product of dynamic race.
There is the benefit of all kinds of albumen powders, branched-chain amino acid BCAAs, L-Glutamine, theanine, collagen on the market at present
Nutriment is filled, but is confined to a certain or a or two kind of combination, the multiple functions amino based on Chinese population data basis mostly
The collaborative research almost blank of acid.The prior art works slow because functional component is single.Especially lack multigroup of large sample
Basic data research, lack comprehensive data of Chinese, therefore it is past to restore after designing corresponding endurance exercise class product
It is not comprehensive toward considering, and not particular for the exercise recovery class product of specific compatriots' constitution, also without being directed to high intensity
The accurate nutritional supplement product of endurance exercise race.These specific amino acids of hydroxyproline, proline be after strenuous exercise easily
The nutrient of loss, and the less addition of existing sports nutrition on the market, are especially applied in limit endurance race.
Invention content
The object of the present invention is to provide a kind of motor function beverages.
Present invention firstly provides a kind of compositions for providing amino acid, vitamin and mineral, including composition
First, composition second and composition third;
The composition for providing amino acid, vitamin and mineral, by composition first, composition second and composition
Third composition.
Composition first is the composition for providing amino acid;The composition first includes following 7 kinds of active ingredient:Hydroxyl dried meat
Propylhomoserin, proline, glutamic acid, Amino Acids in Tea, L-Leu, l-Isoleucine and Valine;Hydroxyproline, proline,
Glutamic acid, Amino Acids in Tea, L-Leu, l-Isoleucine and Valine quality proportioning be followed successively by:0.2-1:0.2-1:
2-5:0.05-0.3:1-3:0.5-1.5:0.5-1.5;
Composition second is vitamin premix;Include following 12 kinds of active ingredient in the composition second:Ingredient I -1, at
Divide I -2, ingredient I -3, ingredient I -4, ingredient I -5, ingredient I -6, ingredient I -7, ingredient I -8, ingredient I -9, ingredient I -10, ingredient I -
11 and ingredient I -12;Ingredient I -1 provides the substance with vitamin A function, and ingredient I -2 provides the object with vitamin B1 function
Matter, ingredient I -3 provide the substance with vitamin B2 function, and ingredient I -4 provides the substance with vitamin B3 function, ingredient I -
5 provide the substance with vitamin B5 function, and ingredient I -6 provides the substance with vitamin B6 function, and the offer of ingredient I -7 has
The substance of Vitamin B9 function, ingredient I -8 provide the substance with vitamin B12 function, and ingredient I -9, which provides, has vitamin C
The substance of function, ingredient I -10 provide the substance with vitamin D function, and ingredient I -11 provides the object with Function of Vitamin-E
Matter, ingredient I -12 provide the substance with biotin function;Ingredient I -1, ingredient I -2, ingredient I -3, ingredient I -4, ingredient I -5,
Ingredient I -6, ingredient I -7, ingredient I -8, ingredient I -9, ingredient I -10, ingredient I -11 and ingredient I -12 proportioning be followed successively by 1100-
1650μg:14.22-21.33mg:7.112-10.67mg:49.11-73.67mg:17.33-26.00mg:7.112-10.67mg:
888.9-1333μg:14.22-21.33μg:255.5-383.3mg:25.55-38.33μg:49.12-73.68mg:121.12-
181.68μg;
Composition third is mineral substance premix;Include following 9 kinds of active ingredient in the composition third:Ingredient II -1, at
Divide II -2, ingredient II -3, ingredient II -4, ingredient II -5, ingredient II -6, ingredient II -7, ingredient II -8 and ingredient II -9;Ingredient
II -1 provides sodium element, and ingredient II -2 provides P elements, and ingredient II -3 provides potassium element, and ingredient II -4 provides magnesium elements, ingredient
II -5 provides calcium constituent, and ingredient II -6 provides ferro element, and ingredient II -7 provides Zn-ef ficiency, and ingredient II -8 provides selenium element, ingredient
II -9 provides iodine;By the sodium element of the offer of ingredient II -1, the P elements provided by ingredient II -2, by the offer of ingredient II -3
Potassium element, by ingredient II -4 provide magnesium elements, by ingredient II -5 provide calcium constituent, by ingredient II -6 provide ferro element,
By ingredient II -7 provide Zn-ef ficiency, by ingredient II -8 provide selenium element and by ingredient II -9 provide iodine proportioning according to
Secondary is 85.19-127.8mg:40.92-61.39mg:85.18-127.8mg:13.08-19.61mg:35.19-52.78mg:
1.2088-1.8134mg:1.4226-2.134mg:2.208-3.312μg:3.614-5.420μg.
In the composition first, hydroxyproline, proline, glutamic acid, theanine, L-Leu, l-Isoleucine and L-
The quality proportioning of valine is followed successively by:0.7:0.9g:3.6g:0.07:2.13:1.12:1.12.
The raw material of the composition first includes:Wheat gluten (concretely concentrating wheat gluten), whole milk powder, hydrolysis breast
Albumin peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid (concretely branched-chain amino acid micro-capsule
Powder) and Amino Acids in Tea.
The raw material group of the composition first becomes:Wheat gluten (concretely concentrating wheat gluten), whole milk powder, hydrolysis
(concretely branched-chain amino acid is micro- for whey protein peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid
Capsule powder) and Amino Acids in Tea.
The raw material of the composition first, wheat gluten (concretely concentrating wheat gluten), whole milk powder, hydrolyzed whey egg
White peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid (concretely branched-chain amino acid microcapsule powder)
It is followed successively by with the quality proportioning of Amino Acids in Tea:6.37:4.5:2.15:1.5:1.5:1.43:2.8:0.28.
In the vitamin premix, ingredient I -1, ingredient I -2, ingredient I -3, ingredient I -4, ingredient I -5, ingredient I -6, at
The proportioning of I -7, ingredient I -8, ingredient I -9, ingredient I -10, ingredient I -11 and ingredient I -12 is divided to be followed successively by 1375 μ g:17.78mg:
8.89mg:61.39mg:21.67mg:8.89mg:1111μg:17.78μg:319.4mg:31.94μg:61.4mg:151.4μg.
In the mineral substance premix, by ingredient II -1 provide sodium element, by ingredient II -2 provide P elements, by
The potassium element for dividing II -3 offer, the magnesium elements provided by ingredient II -4 are carried by the calcium constituent of the offer of ingredient II -5, by ingredient II -6
The ferro element of confession, the Zn-ef ficiency provided by ingredient II -7, the selenium element provided by ingredient II -8 and the iodine provided by ingredient II -9
The proportioning of element is followed successively by 106.5mg:51.16mg:106.49mg:16.35mg:43.99mg:1.52mg:1.78mg:2.76μ
g:4.52μg.
The vitamin premix by ingredient I -1, ingredient I -2, ingredient I -3, ingredient I -4, ingredient I -5, ingredient I -6, at
Divide I -7, ingredient I -8, ingredient I -9, ingredient I -10, ingredient I -11, ingredient I -12 and filler composition.
Ingredient I -1 in per 1g vitamin premixs, ingredient I -2, ingredient I -3, ingredient I -4, ingredient I -5, ingredient I -6, at
Point I -7, the content of ingredient I -8, ingredient I -9, ingredient I -10, ingredient I -11 and ingredient I -12 be followed successively by 1100-1650 μ g,
14.22-21.33mg,7.112-10.67mg,49.11-73.67mg,17.33-26.00mg,7.112-10.67mg,888.9-
1333μg,14.22-21.33μg,255.5-383.3mg,25.55-38.33μg,49.12-73.68mg,121.12-181.68μ
g。
The mineral substance premix is by ingredient II -1, ingredient II -2, ingredient II -3, ingredient II -4, ingredient II -5, ingredient
II -6, ingredient II -7, ingredient II -8, ingredient II -9 and filler composition.
The sodium element that is there is provided by ingredient II -1 in per 1g mineral substance premixes, the P elements provided by ingredient II -2, by
The potassium element for dividing II -3 offer, the magnesium elements provided by ingredient II -4 are carried by the calcium constituent of the offer of ingredient II -5, by ingredient II -6
The ferro element of confession, the Zn-ef ficiency provided by ingredient II -7, the selenium element provided by ingredient II -8 and the iodine provided by ingredient II -9
The content of element be followed successively by 85.19-127.8mg, 40.92-61.39mg, 85.18-127.8mg, 13.08-19.61mg,
35.19-52.78mg,1.2088-1.8134mg,1.4226-2.134mg,2.208-3.312μg,3.614-5.420μg。
Ingredient I -1 in per 1g vitamin premixs, ingredient I -2, ingredient I -3, ingredient I -4, ingredient I -5, ingredient I -6, at
Point I -7, the content of ingredient I -8, ingredient I -9, ingredient I -10, ingredient I -11 and ingredient I -12 be followed successively by 1375 μ g, 17.78mg,
8.89mg,61.39mg,21.67mg,8.89mg,1111μg,17.78μg,319.4mg,31.94μg,61.4mg,151.4μg。
The sodium element that is there is provided by ingredient II -1 in per 1g mineral substance premixes, the P elements provided by ingredient II -2, by
The potassium element for dividing II -3 offer, the magnesium elements provided by ingredient II -4 are carried by the calcium constituent of the offer of ingredient II -5, by ingredient II -6
The ferro element of confession, the Zn-ef ficiency provided by ingredient II -7, the selenium element provided by ingredient II -8 and the iodine provided by ingredient II -9
The content of element is followed successively by 106.5mg, 51.16mg, 106.49mg, 16.35mg, 43.99mg, 1.52mg, 1.78mg, 2.76 μ
g,4.52μg。
The ingredient I -1 is axerophtholum aceticum, and the ingredient I -2 is thiamine hydrochloride, and the ingredient I -3 is riboflavin,
The ingredient I -4 is niacinamide, and the ingredient I -5 is D-VB5 calcium, and the ingredient I -6 is puridoxine hydrochloride, the ingredient I -7
For Vitamin B9, the ingredient I -8 is cyanocobalamin, and the ingredient I -9 is L-AA sodium, and the ingredient I -10 is vitamin
D3, the ingredient I -11 are dl- α-D-α-tocopherol acetate, and the ingredient I -12 is D-Biotin.
The ingredient II -1 be sodium citrate and/or disodium hydrogen phosphate, the ingredient II -2 be disodium hydrogen phosphate, it is described at
Point II -3 is potassium citrate and/or potassium chloride, and the ingredient II -4 is magnesium carbonate, and the ingredient II -5 is calcium carbonate, it is described at
It is ferric pyrophosphate to divide II -6, and the ingredient II -7 is zinc sulfate, and the ingredient II -8 is sodium selenite, and the ingredient II -9 is iodine
Sour potassium.
The present invention also protects a kind of product, including product A and product B.
The product is made of product A and product B.
The raw material of product A includes:Wheat gluten (concretely concentrating wheat gluten), whole milk powder, hydrolyzing lactoalbumin
Peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid (concretely branched-chain amino acid microcapsule powder), tea
The dimension life of leaf amino acid, crystal diabetin, oligofructose, sodium carboxymethylcellulose, resistant dextrin, taurine, any description above
The mineral substance premix of plain premix and any description above;Wheat gluten (concretely concentrating wheat gluten), whole milk powder,
Hydrolyzing lactoalbumin peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid (concretely branched-amino
Sour microcapsule powder), Amino Acids in Tea, crystal diabetin, oligofructose, sodium carboxymethylcellulose, resistant dextrin, taurine, vitamin
The quality proportioning of premix and mineral substance premix is followed successively by 6.37:4.5:2.15:1.5:1.5:1.43:2.8:0.28:5.07:
0.9:0.8:1.72:0.04:0.13:0.81.
The raw material group of product A becomes:Wheat gluten (concretely concentrating wheat gluten), whole milk powder, hydrolyzed whey egg
White peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid (concretely branched-chain amino acid microcapsule powder),
The dimension of Amino Acids in Tea, crystal diabetin, oligofructose, sodium carboxymethylcellulose, resistant dextrin, taurine, any description above
The mineral substance premix of raw element premix and any description above;Wheat gluten (concretely concentrating wheat gluten), whole milk
Powder, hydrolyzing lactoalbumin peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid (concretely branch
Amino acid microcapsule powder), Amino Acids in Tea, crystal diabetin, oligofructose, sodium carboxymethylcellulose, resistant dextrin, taurine, dimension
The quality proportioning of raw element premix and mineral substance premix is followed successively by 6.37:4.5:2.15:1.5:1.5:1.43:2.8:0.28:
5.07:0.9:0.8:1.72:0.04:0.13:0.81.
The raw material of product B includes:The vitamin premix of any description above, the minerals premix of any description above
The luxuriant Cillium of material, Sucralose, Guarana extract, taurine, circle,Abundant power peptide, maltodextrin, poly- Portugal
It is grape sugar, DEXTROSE ANHYDROUS, crystal diabetin, isomalt, PURE WHEY, soybean separation protein white powder, medium chain fatty acid, strange
Sub- seed powder, coconut slurry powder and shredded coconut stuffing;Vitamin premix, mineral substance premix, Sucralose, Guarana extract, taurine, circle
Luxuriant Cillium,Abundant power peptide, maltodextrin, polydextrose, DEXTROSE ANHYDROUS, crystal diabetin, different malt ketone
Sugar alcohol, PURE WHEY, soybean separation protein white powder, medium chain fatty acid, strange sub- seed powder, coconut slurry powder and shredded coconut stuffing quality proportioning successively
For:1.2:21:0.03:1.1:1.2:1.6:8.3:12.04:12.5:41.63:24.9:24.9:20.8:24.9:33.2:8.3:
49.9:12.5.
The raw material group of product B becomes:The vitamin premix of any description above, the minerals premix of any description above
The luxuriant Cillium of material, Sucralose, Guarana extract, taurine, circle,Abundant power peptide, maltodextrin, poly- Portugal
It is grape sugar, DEXTROSE ANHYDROUS, crystal diabetin, isomalt, PURE WHEY, soybean separation protein white powder, medium chain fatty acid, strange
Sub- seed powder, coconut slurry powder and shredded coconut stuffing;Vitamin premix, mineral substance premix, Sucralose, Guarana extract, taurine, circle
Luxuriant Cillium,Abundant power peptide, maltodextrin, polydextrose, DEXTROSE ANHYDROUS, crystal diabetin, different malt ketone
Sugar alcohol, PURE WHEY, soybean separation protein white powder, medium chain fatty acid, strange sub- seed powder, coconut slurry powder and shredded coconut stuffing quality proportioning successively
For:1.2:21:0.03:1.1:1.2:1.6:8.3:12.04:12.5:41.63:24.9:24.9:20.8:24.9:33.2:8.3:
49.9:12.5.
The preparation method of product A, includes the following steps:
(1) vitamin premix, mineral substance premix, Amino Acids in Tea, taurine, mixing, obtain batch mixing A;
(2) batch mixing A, soybean separation protein white powder, branched-chain amino acid (concretely branched-chain amino acid microcapsule powder), resistance paste
Essence, sodium carboxymethylcellulose, oligofructose, collagen, PURE WHEY, hydrolyzing lactoalbumin peptide, whole milk powder, crystallization fruit
Sugar, wheat gluten (concretely concentrating wheat gluten), mixing, obtain the product.
The function of the product A is following (a1) or (a2) or (a3):
(a1) amino acid is provided;
(a2) drinks taken after movement are prepared;
(a3) as the drinks taken after movement.
The preparation method of product B, includes the following steps:
(1) Sucralose, Guarana extract, vitamin premix, mineral substance premix, mixing, obtain batch mixing A;
(2) the luxuriant Cillium of batch mixing A, taurine, circle, mixing obtain mixed material B;
(3) mixed material B,Abundant power peptide, maltodextrin, polydextrose, mixing, obtain batch mixing C;
(4) batch mixing C, DEXTROSE ANHYDROUS, crystal diabetin, isomalt, PURE WHEY (concretely condensed whey
Albumen powder), soybean separation protein white powder, medium chain fatty acid (concretely medium chain fatty acid microcapsule powder), strange sub- seed powder, coconut slurry powder,
Shredded coconut stuffing is sufficiently mixed, and obtains the product.
The function of the product B is following (b1), (b2) or (b3):
(b1) vitamin and mineral is provided;
(b2) drinks taken before movement are prepared;
(b3) as the drinks taken before movement.
Composition or product provided by the invention can be used for field of food and field of health care products.
Composition or product provided by the invention can be used for various dosage forms.For example, solid beverage, liquid beverage, energy glue,
Energy stick (nutrition bar), capsule, tablet etc..
The present invention also protects the application of any description above composition or any description above product, for following (c1) or
(c2):
(c1) motor function beverage is prepared;
(c2) it is used as motor function beverage.
The drinks are solid beverage or liquid beverage.When the drinks are solid beverage, it can be reconstituted with water
After drink.
Composition provided by the invention is based on to the comprehensive multigroup data of human body before and after endurance exercise, by monitoring nutrition
Plain situation of change passes through so that it is determined that functional nutrient and being easy to run off nutrient and concentrates wheat gluten, whole milk powder, hydrolysis
Whey protein peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid microcapsule powder and Amino Acids in Tea are several
The combination of kind of raw-food material, realize branched-chain amino acid BCAAs (valine, leucine, isoleucine), glutamine, theanine,
The accurate supplement of the aminoacid ingredients such as hydroxyproline, proline, quicklys promote the body recovery after endurance exercise.
The achievable effect of drinks is:Inhibit creatine kinase fluctuation, it is different to improve valine, L-Leu, L-
Leucine, proline level can slow down injury gained in sports by drinks after targetedly supplementing movement, be damaged after accelerated motion
The reparation of wound.Composition maximum feature provided by the invention is to be based on multigroup data, integrally the element that supplements the nutrients comprehensively, to
Combination of the effect better than single or individual nutrients.
The achievable effect of drinks is:Compared with not taking the drinks, flesh during user moves
Acid kinase level is more stable, vitamin B1 higher level and vitamin B6 higher level.The achievable effect of drinks
For:Compared with not taking the drinks, slow down injury gained in sports, the reparation damaged after accelerated motion improves ontology comfort level.
The present invention has filled up the blank of the domestic accurate nutrient of limit endurance race.
Description of the drawings
Fig. 1 is that micro-element is averaged stability bandwidth.
Fig. 2 is that trace element/macroelement be averaged stability bandwidth and toxic heavy metal is averaged stability bandwidth.
Fig. 3 is with the creatine kinase content in time point athletes'serum.
Fig. 4 is the horizontal variation diagram of subject's different time points creatine kinase.
Fig. 5 is the horizontal variation diagram of subject's different time points vitamin B1.
Fig. 6 is the horizontal variation diagram of subject's different time points vitamin B6.
Fig. 7 is that amino acid is averaged stability bandwidth.
Fig. 8 is that hormone is averaged stability bandwidth.
Fig. 9 is creatine kinase variation diagram in different time points.
Figure 10 is the horizontal variation diagram of subject's different time points creatine kinase.
Figure 11 is subject's different time points valine levels variation diagram.
Figure 12 is the horizontal variation diagram of subject's different time points l-Isoleucine.
Figure 13 is the horizontal variation diagram of subject's different time points L-Leu.
Figure 14 is subject's different time points proline level variation diagram.
Specific implementation mode
Embodiment below facilitates a better understanding of the present invention, but does not limit the present invention.Experiment in following embodiments
Method is unless otherwise specified conventional method.Test material as used in the following examples is unless otherwise specified certainly
What routine biochemistry reagent shop was commercially available.Quantitative test in following embodiment is respectively provided with three repeated experiments, as a result makes even
Mean value.The content of each amino acid is detected using the assay method of amino acid in food in GB/T 5009.124-2003.Tea ammonia
Sour (L-Theanine) is distinctive free amino acid in tealeaves, is glutamic acid gamma-buserelin.Using GB/T 8314-2013
Theanine content in the assay method detection Amino Acids in Tea of middle tea free amino acid total amount.Maltodextrin:Western king's sugar industry has
Limit company.
800 drift sand limit races are first the uninterrupted of extra long distance of China, auto-navigation, from heavy burden cross-country race race;Pole
Limit test:High load capacity motion state, extra long distance, bad environments are changeable;It feeds limited, rest to lack, tests sportsman's physiology
Function.Hua Da movement as mechanism under Hua Da gene, for sportsman provide pre-games, games and post-games, post-games two weeks it is comprehensive
Detection service.It assesses, and provides from gene, metabolism, physiology of exercise, psychology, the mass motion health of sportsman etc.
Personalized recommendations, the exercise program to formulate more science provide foundation.
The formula research and development of drinks before embodiment 1, movement
One, it is formulated R&D process
Micro-element stability bandwidth=(post-games level-pre-games is horizontal)/pre-games level × 100%.The micro-element stability bandwidth that is averaged is shown in
Fig. 1, negative value are horizontal reduction, and positive value increases to be horizontal.The average stability bandwidth of Vitamin B9 is -34.64%, and vitamin K1 is put down
Equal stability bandwidth is -22.16%, and the average stability bandwidth of vitamin B1 is -12.08%, and the average stability bandwidth of vitamin D is
12.88%, the average stability bandwidth of vitamin A is 14.45%, and the average stability bandwidth of vitamin B5 is 26.38%, vitamin E
Average stability bandwidth is 37.37%, and the average stability bandwidth of vitamin B12 is 43.97%, the average stability bandwidth of 5-methyltetrahydrofolate
It is 61.12%, the average stability bandwidth of vitamin B6 is 61.38%, and the average stability bandwidth of vitamin B2 is 89.46%.It is transported in match
The vitamin being lost in is mobilized to be followed successively by:Vitamin B9, vitamin K1, vitamin B1.Vitamin B9, K1 are primarily present in new bud green
In color vegetables, the loss of both vitamins is likely to few related to sportsman's fresh green vegetables intake on big gobi.In the present
Sportsman can carry the tablet progress of relevant Vitamin B9, vitamin K1, vitamin B1 in 800 drift sand limit match afterwards
Supplement, it will help race plays.
Trace element/macroelement stability bandwidth=(post-games level-pre-games is horizontal)/pre-games level × 100%.A toxic huge sum of money
Belong to stability bandwidth=(post-games level-pre-games is horizontal)/pre-games level × 100%.Iron, copper, zinc, cobalt, manganese, chromium, selenium, strontium, arsenic belong to
Trace element.Magnesium belongs to macroelement.Lead, cadmium, mercury belong to toxic heavy metal.Trace element/macroelement be averaged stability bandwidth with
The toxic heavy metal stability bandwidth that is averaged is shown in Fig. 2, negative value be it is horizontal reduce, positive value increases to be horizontal.The average stability bandwidth of cobalt be-
32.8%, the average stability bandwidth of zinc is -21.8%, and the average stability bandwidth of lead is -17.2%, the average stability bandwidth of strontium is -
13.9%, the average stability bandwidth of cadmium is -13.5%, and the average stability bandwidth of mercury is -8.60%, the average stability bandwidth of iron is -
4.16%, the average stability bandwidth of manganese is -3.11%, and the average stability bandwidth of selenium is 2.41%, and the average stability bandwidth of arsenic is 3.79%,
The average stability bandwidth of magnesium is 6.90%, and the average stability bandwidth of copper is 16.67%, and the average stability bandwidth of chromium is 94.46%.800 streams
The match of the husky limit contributes to the excretion of three kinds of toxic heavy metals (lead, cadmium, mercury), five kinds in nine kinds of trace elements (cobalt, zinc, strontium,
Iron, manganese) it is lost in, it is proposed that sportsman in competing from now on and post-games pays attention to this five kinds of micro- supplements.
Four kinds of creatine kinase, lactic dehydrogenase, aspartate aminotransferase, alanine aminotransferase muscle metabolism enzymes
It can be used for evaluating muscle damage degree.Four kinds of muscle enzymic change trend are close:Pre-games is normal;RP6 points (the 6th supply in match
Point) rise to peak;Post-games is declined, and is not restored to normal level;Post-games continues to decline for two weeks, but does not restore still
To pre-games normal level.The result shows that the match of the 800 drift sand limit has a degree of damage, post-games or even match to sportsman's muscle
Do not restore still to pre-games normal level within two weeks afterwards.Creatine kinase content in different time points athletes'serum is shown in Fig. 3.Fig. 3
In, time point 1 is before match starts, and time point 2 is (the 6th supply point) after match starts 2 days, and time point 3 is end of match
Afterwards, after time point 4 is end of match 2 weeks.
By being continued to monitor to pre-games, post-games different phase sportsman, find:Water soluble vitamin is lost in seriously, such as
Vitamin B9, vitamin B1, while vitamin K1 turnover rate is also higher;Trace element cobalt, zinc, strontium, iron, manganese are lost in, match
Afterwards it should be noted that this five kinds of micro- supplements;The limit matches the excretion for contributing to heavy metal lead, cadmium, mercury.Therefore corresponding pre-games,
In match, the nutritional support of post-games be very important a link, targetedly supplementing corresponding electrolytes and minerals can
To improve the ontology comfort level of sportsman, accelerate the reparation of body items function.
Two, it is formulated core design
It is designed adjustment on the basis of step 1 data, the formula core design finally proposed is shown in Table 1.
Table 1
Ingredient names | Quality proportioning | Daily design flow |
Substance with vitamin B1 function | 0.2-6 | 0.2~6mg |
Substance with vitamin B2 function | 0.2-4 | 0.2~4mg |
Substance with vitamin B6 function | 0.2-4 | 0.2~4mg |
Substance with Vitamin B9 function | 0.05-0.5 | 50~500 μ g |
Substance with vitamin C function | 10-300 | 10~300mg |
The substance of Zn-ef ficiency is provided | 2-12 | 2~12mg |
The substance of ferro element is provided | 2-20 | 2~20mg |
The substance of Zn-ef ficiency is provided, quality proportioning refers to the quality proportioning for the Zn-ef ficiency and other components that it is provided, often
Day design flow refers to the daily design flow for the Zn-ef ficiency that it is provided.The substance of ferro element is provided, quality proportioning refers to that it is carried
The quality proportioning of the ferro element of confession and other components, daily design flow refer to the daily design flow for the ferro element that it is provided.
Embodiment 2, premix preparation
One, vitamin premix
Vitamin premix is made of function raw material and filler.Filler is maltodextrin.Per 1g vitamin premixs
In the content of each function raw material be shown in Table 2.
Table 2
Vitamin premix for embodiment 3 is made of function raw material and filler.Filler is maltodextrin.Unit
The content of each function raw material is shown in Table 3 in the vitamin premix of quality.
Table 3
Two, mineral substance premix
Mineral substance premix is made of function raw material and filler.Filler is maltodextrin.Per 1g mineral substance premixes
In each function raw material composition and the amount of corresponding function element that provides of each function raw material be shown in Table 4.
Table 4
Mineral substance premix for embodiment 3 is made of function raw material and filler.Filler is maltodextrin.Unit
The content of each function raw material is shown in Table 5 in the mineral substance premix of quality.
Table 5
The preparation (solid beverage) of drinks before embodiment 3, movement
Drinks are 1 people, 1 gift before every 1 bag of movement, and 10,000 bags of formula is shown in Table 6.That is, drinks before every 1 bag of movement
For 30g, wherein containing 0.12g vitamin premixs and 2.1g mineral substance premixes.
Table 6
DEXTROSE ANHYDROUS, crystal diabetin, isomalt and polydextrose are as energy extender and sweetener.
Maltodextrin is as filler.
Concentrated whey protein powder, soybean separation protein white powder,Abundant power peptide is as amino acid supplements.
Medium chain fatty acid microcapsule powder is as energy extender.
Strange Asia seed powder is as unsaturated fatty acid replenishers.
Circle bud Cillium will justify luxuriant isapgol husk and crush to obtain, as thickener.
Coconut slurry powder and shredded coconut stuffing are as flavoring agent.
Sucralose is as sweetener.
Taurine is as basic nutrient prime replenisher.
Guarana extract is as caffeine replenishers.
Preparation flow is as follows:
1, Sucralose, Guarana extract, vitamin premix, mineral substance premix, are sufficiently mixed, and obtain batch mixing A.
2, the luxuriant Cillium of batch mixing A, taurine, circle, is sufficiently mixed, obtains mixed material B.
3, mixed material B,Abundant power peptide, maltodextrin, polydextrose, are sufficiently mixed, and obtain batch mixing C.
4, batch mixing C, DEXTROSE ANHYDROUS, crystal diabetin, isomalt, concentrated whey protein powder, soybean protein isolate
Powder, medium chain fatty acid microcapsule powder, strange sub- seed powder, coconut slurry powder, shredded coconut stuffing, are sufficiently mixed, obtain batch mixing D.
5, batch mixing D is dispensed, every bag of 30g.
The compliance test result of drinks before embodiment 4, movement
Using random, parallel control clinical test methods, by 60 running athletes (being the volunteer of informed consent)
It is randomly divided into two groups, every group 30.
Experimental group (per as follows per capita):
It tests the 0th day evening 8 points (time1), acquires venous blood;
It tests the 1st day to the 4th day:Every morning carries out 20 kilometers of long-distance runnings (running speed control at 10km/ hours), running preceding 1
Hour takes drinks (being taken after being reconstituted with boiling water) before movement prepared by one bag of embodiment 3;
It tests the 1st day evening 8 points (time1), the 4th day evening of experiment 8 points (time3), the 7th day evening of experiment 8 points (time4), examination
It tests the 14th day evening (time5) at 8 points, acquires venous blood respectively.
Control group does not take drinks before movement prepared by embodiment 3, other same experimental groups.
The content of creatine kinase (CK), vitamin B1, vitamin B6 in the venous blood blood plasma of detection 5 time points acquisition
Level assesses its injury gained in sports degree.
Creatine kinase has certain direction meaning to skeletal muscle injury.Creatine kinase normal range (NR) in serum:8~60U/L.
The horizontal variation diagram of subject's different time points creatine kinase is shown in Fig. 4 (ordinate in Fig. 4 is U/L).Control group exceeds normal model
Hundred to thousand times are enclosed, experimental group relative fluctuation range is small.
The most important coenzyme that functions as participates in glycometabolism to vitamin B1 during exercise, is the tonic to regain one's strength.Cause
This, when Vitamin B1 deficiency, oxidation sugared first energy supply can be obstructed, and cause energy supply insufficient;The intermediate product third of glycometabolism
Ketone acid accumulation can influence nervous function, nerve impulse and delayed conduction;Lactic acid accumulation can cause tired appearance too early, damage aerobic
Locomitivity.Often occur Vitamin B1 deficiency phenomenon in sport people, increases the mental activity of amount of exercise and high intensity all
Meeting consumption of energy increases, and the demand to vitamin B1 also accordingly increases, higher and higher with temperature, and movement perspiration is more, and dimension is given birth to
Plain B1 excretes increase with sweat, and 4/5ths vitamin B1 may be sometimes lacked in professional athlete's body.Vitamin
B1 and nervimuscular normal conduction function are also closely bound up.Lactic acid is accumulated when Vitamin B1 deficiency easily causes movement in body
Increase, that is, post exercise muscle is ached, and makes organism fatigue, it is also possible to influence the function of heart.Internal vitamin B1 fills
When sufficient, so that it may which glycogen aerobic metabolism when promoting to move improves the speed and endurance, And and blood breast after also accelerating of body
The elimination of acid greatly reduces post exercise and aches sense.Vitamin B1 normal range (NR) in serum:2.41-9.03ng/mL.Subject
The horizontal variation diagram of different time points vitamin B1 is shown in Fig. 5 (ordinate in Fig. 5 is a μm ol/L).The vitamin of experimental group subject
B1 contents are higher than control group subject.
When vitamin B6 is human motion in glycometabolism pyruvic dehydrogenase coenzyme constituent, but also passed with nerve
The synthesis of matter and exploded relationship are close.Vitamin B6 normal range (NR) in serum:2.1-21.7ng/mL.Subject's different time points
The horizontal variation diagram of vitamin B6 is shown in Fig. 6.The vitamin B6 content of experimental group subject is higher than control group subject.
By before running to experimental group, the piecewise analysis of same individual different time and experimental group and control group after running
It compares analysis and finds that, compared to experimental group, control group creatine kinase has fluctuation, vitamin B1 and the vitamin B6 content of bigger more
It is low.The result shows that injury gained in sports can be slowed down by drinks before targetedly supplementing the movement of the preparation of embodiment 3, accelerate
The reparation damaged after movement improves the ontology comfort level of sportsman.
Embodiment 5, premix compliance test result
30 running athletes (being the volunteer of informed consent) are tested.
Substantially with the experimental group of embodiment 4, difference is only that with 0.12g vitamin premixs (for embodiment 3 method
Vitamin premix) and the preceding drinks of 2.1g mineral substance premixes (mineral substance premix for being used for embodiment 3) replacement movement.
The content water of creatine kinase (CK), vitamin B1, vitamin B6 in subject's different time points venous blood serum
The flat experimental group with embodiment 4 is without significant difference.
The formula research and development of drinks after embodiment 6, movement
One, it is formulated R&D process
Amino acid stability bandwidth=(post-games level-pre-games is horizontal)/pre-games level × 100%.The amino acid stability bandwidth that is averaged is shown in
Fig. 7, negative value are horizontal reduction, and positive value increases to be horizontal.In Fig. 7, be followed successively by from left to right hydroxyproline, proline, ornithine,
Valine, alanine, sarcosine, cysteine, isoleucine, leucine, phosphoserine, citrulling, glycine, Soviet Union's ammonia
Acid, γ-oxylysine, lysine, serine, tryptophan, alpha-amido n-butyric acie, asparagine.The average wave of hydroxyproline
It is the average stability bandwidth of -47%, ornithine is being averaged for -44%, valine that dynamic rate, which is the average stability bandwidth of -54%, proline,
It is the average stability bandwidth of -38%, sarcosine is -32%, cysteine that stability bandwidth, which is the average stability bandwidth of -39%, alanine,
It is -24%, phosphoric acid that averagely stability bandwidth, which is the average stability bandwidth that the average stability bandwidth of -30%, isoleucine is -24%, leucine,
The average stability bandwidth of serine be -22%, citrulling average stability bandwidth be -22%, glycine average stability bandwidth be -
22%, the average stability bandwidth of threonine is -20%, the average stability bandwidth of γ-oxylysine is being averaged for -17%, lysine
Stability bandwidth be -11%, serine average stability bandwidth be -9.3%, tryptophan average stability bandwidth be -7.5%, alpha-amido just
The average stability bandwidth of butyric acid is that the average stability bandwidth of -6.4%, asparagine is -4.7%.3 kinds of branched-chain amino acids of sportsman
(BCAA) (valine, isoleucine, leucine) is lost in more:The loss ratio of these three amino acid is 24%-40%.Branch
The loss of amino acid BCAAs accelerates muscle breakdown process, generates stronger sports fatigue sense, and locomitivity declines.Movement
Member's maximum two kinds of amino acid of turnover rate is hydroxyproline and proline.Contain a high proportion of hydroxyproline, dried meat in collagen
Propylhomoserin, and these specific amino acids are the nutrients easily lost after strenuous exercise.Collagen not only individual generation,
It plays an important role as other connective tissues in differentiation and forming process, and has pole with the aging of body and disease
Its close relationship.
Hormonal fluctuations rate=(post-games level-pre-games is horizontal)/pre-games level × 100%.The hormone stability bandwidth that is averaged is shown in Fig. 8,
Negative value is to reduce, and positive value is raising.In Fig. 8, it is followed successively by testosterone/cortisol, testosterone, 17-OH progesterone, progesterone, hero from left to right
Alkene diketone, dehydrobenzene, 11-deoxycorticosterone, cortisone, Compd S 11-deoxycortisol, estradiol, aldosterone, dihydrotestosterone,
Dehydroepiandrosterone sulfate, cortisol, oestrone, cortisone.The average stability bandwidth of testosterone/cortisol is -75%, the average wave of testosterone
Dynamic rate is -63%, and the average stability bandwidth of 17-OH progesterone is -47%, and the average stability bandwidth of progesterone is -40%, and androstenedione is put down
Equal stability bandwidth is -38%, and the average stability bandwidth of dehydrobenzene is -12%, and the average stability bandwidth of 11-deoxycorticosterone is
3.33%, the average stability bandwidth of cortisone is 3.86%, and the average stability bandwidth of Compd S 11-deoxycortisol is 16.4%, estradiol
Average stability bandwidth is 58.7%, the average stability bandwidth of aldosterone is 69.6%, and the average stability bandwidth of dihydrotestosterone is 91.6%, sulphur
The average stability bandwidth of sour dehydrobenzene is 107%, and the average stability bandwidth of cortisol is 126%, and the average stability bandwidth of oestrone is
165%, the average stability bandwidth of cortisone is 230%.Testosterone:It is lost in, muscle mass is accelerated.Cortisol:It increases, sports fatigue increases
Add, carbohydrate, fat, breaks down proteins are accelerated.Testosterone/Cortisol Ratio:Attenuating amplitude is more than 30%, and sportsman belongs on the whole
Excessive movement.
Four kinds of creatine kinase, lactic dehydrogenase, aspartate aminotransferase, alanine aminotransferase muscle metabolism enzymes
It can be used for evaluating muscle damage degree.Variation diagram is shown in Fig. 9 to creatine kinase in different time points.In Fig. 9, time point 1 is match
Before beginning, time point 2 is (the 6th supply point) after match starts 2 days, and time point 3 is after end of match, time point 4 is that match is tied
After beam 2 weeks.Four kinds of muscle enzymic change trend are close:Pre-games is normal;RP6 points (the 6th supply point) rise to peak in match;Match
Declined afterwards, is not restored to normal level;Post-games continues to decline for two weeks, but does not restore still to pre-games normal level.Eight
The match of the hundred drift sand limit has a degree of damage, post-games or even post-games not to restore within two weeks normal to pre-games still sportsman's muscle
It is horizontal.
By being continued to monitor to pre-games, games and post-games different phase sportsman, it is found that sportsman's amino acid levels are lost in
Rate is larger, especially branched-chain amino acid, proline, hydroxyproline.Hormonal readiness (testosterone/Cortisol Ratio) lowers amplitude simultaneously
More than 30%, reflect that prolonged endurance exercise has apparent negative effect to the body of sportsman, and restore slower.Cause
The nutritional support of this corresponding pre-games, games and post-games is very important a link, targetedly supplements corresponding amino
Acid, the relevant hormonal readiness of adjusting can improve the ontology comfort level of sportsman, accelerate the reparation of body items function.
Two, it is formulated core design
Formula core design is shown in Table 7.
Table 7
Ingredient names | Quality proportioning | Daily design flow |
Hydroxyproline | 0.2-1 | 0.2-1g |
Proline | 0.2-1 | 0.2-1g |
Glutamic acid | 2-5 | 2-5g |
Theanine | 0.05-0.3 | 0.05-0.3g |
L-Leu | 1-3 | 1-3g |
L-Isoleucine | 0.5-1.5 | 0.5-1.5g |
Valine | 0.5-1.5 | 0.5-1.5g |
Embodiment 7, premix preparation
One, vitamin premix
Vitamin premix for embodiment 8 is made of function raw material and filler.Filler is maltodextrin.Unit
The content of each function raw material is shown in Table 8 in the vitamin premix of quality.
Table 8
Two, mineral substance premix
Mineral substance premix for embodiment 8 is made of function raw material and filler.Filler is maltodextrin.Unit
The content of each function raw material is shown in Table 9 in the mineral substance premix of quality.
Table 9
The preparation (solid beverage) of drinks after embodiment 8, movement
Drinks are 1 people, 1 gift after every 1 bag of movement, and drinks are 30g after every 1 bag of movement.Drinks after movement
Raw material composition, per 30g after movement in drinks the raw material dosage (g), per 30g after movement in drinks by the raw material
The nutrient amount (g) of offer is shown in Table 10.
Table 10
Concentration wheat gluten in embodiment is SYRAL wheat glutens, Shanghai victory at,500, http://
Www.jebsenindustrial.com/%E5%85%B3%E4%BA%8E%E6%88%91%E4% BB%AC/%
E5%90%88%E4%BD%9C%E4%BC%99%E4%BC%B4/syral/syral%E5%B0%8F %E9%
BA%A6%E8%9B%8B%E7%99%BD/.
Whole milk powder used in embodiment is permanent natural whole milk powder, article No. 113120.
Hydrolyzing lactoalbumin peptide used in embodiment isAbundant power peptide:Royal DSM, article No. 5007143.
PURE WHEY used in embodiment is HILMAR8010 concentrated whey protein powders.
Soybean separation protein white powder used in embodiment is 787 soybean separation protein white powders of Du Pont SUPRO.
Collagen used in embodiment is Isin glue collagen peptide:Shanghai system garden health care science and technology, article No. GBB-50SP
757。
Branched-chain amino acid microcapsule powder used in embodiment:Dalian Yi Nuo Biological Co., Ltd., article No. 60102-P.
Amino Acids in Tea used in embodiment be natural tea amino acid (Shanghai promise moral biology is Industrial Co., Ltd.,
TeanovaTM L20 natural teas amino acid), network address http://www.novanat.com/showProduct.asplag
=c&Id=80.
Crystal diabetin:BaoLingBao Biology Co., Ltd, article No. QR0256.Oligofructose:SENSUS, article No.
513E801602.Sodium carboxymethylcellulose:Changzhou state space environmental protection science and technology, article No. FH6.Resistant dextrin:Ba Weita (Shanghai) quotient
Trade Co., Ltd, article No. 338111W.Taurine:The long-range Life Science and Technology Co., Ltd in Hubei, article No. C002-
M1710621.Crystal diabetin is as energy extender and sweetener.Oligofructose is as sweetener and enteron aisle buffer.Carboxymethyl
Sodium cellulosate is as adhesive.Resistant dextrin is as filler.Taurine is as basic nutrient prime replenisher.
Preparation flow is as follows:
1, vitamin premix, mineral substance premix, Amino Acids in Tea, taurine, are sufficiently mixed, and obtain batch mixing A.
2, batch mixing A, soybean separation protein white powder, branched-chain amino acid microcapsule powder, resistant dextrin, sodium carboxymethylcellulose, oligomeric
Fructose, collagen, PURE WHEY, hydrolyzing lactoalbumin peptide, whole milk powder, crystal diabetin, concentration wheat gluten, it is fully mixed
It closes, obtains mixed material B.
3, mixed material B is dispensed, every bag of 30g.
After testing, after being moved per 30g in drinks, the content of glutamic acid is 3.6g, and the content of proline is 0.9g, hydroxyl
The content of proline is 0.7g, and the content of L-Leu is 2.13g, and the content of l-Isoleucine is 1.12g, and Valine contains
Amount is 1.12g, and the content of theanine is 0.07g.
The compliance test result of drinks after embodiment 9, movement
Using random, parallel control clinical test methods, by 60 running athletes (being the volunteer of informed consent)
It is randomly divided into two groups, every group 30.
Experimental group (per as follows per capita):
It tests the 0th day evening 8 points (time1), acquires venous blood;
It tests the 1st day to the 4th day:Every morning carries out 20 kilometers of long-distance runnings (running speed control at 10km/ hours), 1 after running
Hour takes drinks (being taken after being reconstituted with boiling water) after movement prepared by one bag of embodiment 8;
It tests the 1st day evening 8 points (time1), the 4th day evening of experiment 8 points (time3), the 7th day evening of experiment 8 points (time4), examination
It tests the 14th day evening (time5) at 8 points, acquires venous blood respectively.
Control group does not take drinks after movement prepared by embodiment 8, other same experimental groups.
The major function of branched-chain amino acid (valine, leucine, isoleucine):Improve locomitivity, delay fatigue.Branch
Chain amino acid is 3 kinds in 8 kinds of amino acid necessary to body of general name, is the essential nutrient of muscle, accounts for constituting muscle
Amino acid in 30%-40%.The function of branched-chain amino acid:It is in close relations with Human Stamina, can be prolonged
Endurance exercise provides energy reserve;Promote the synthesis of muscle protein;Antidecomposition acts on, and helps to prevent protein breakdown and muscle
It loses, helps to protect muscle;The periphery mechanism for causing exercise induced fatigue is adjusted, the appearance of exercise induced fatigue is postponed;After movement
Supplement branched-chain amino acid can also promote the recovery of exercise induced fatigue.
Measure creatine kinase (CK), valine, L-Leu, the different bright ammonia of L- in the venous blood blood plasma of 5 time points acquisition
The level of acid, proline, assesses its injury gained in sports degree.
The horizontal variation diagram of subject's different time points creatine kinase is shown in Figure 10 (ordinate unit is U/L).Subject is different
Time point valine levels variation diagram is shown in Figure 11 (ordinate unit is μm ol/L).Subject's different time points l-Isoleucine water
Flat variation diagram is shown in Figure 12 (ordinate unit is μm ol/L).The horizontal variation diagram of subject's different time points L-Leu is shown in Figure 13
(ordinate unit is μm ol/L).Subject's different time points proline level variation diagram is shown in that (ordinate unit is μm ol/ to Figure 14
L).Compared with experimental group, the creatine kinase level of control group has a fluctuation of bigger, valine, L-Leu, l-Isoleucine,
Proline level is lower.The result shows that fortune can be slowed down by drinks after targetedly supplementing the movement of the preparation of embodiment 3
Dynamic damage, the reparation damaged after accelerated motion.
Embodiment 10, provide amino acid composition compliance test result
In experimental group, the composition (table 7 is 1 day person-portion) that amino acid is provided shown in volunteer's table 11, generation is given once daily
For drinks after movement, other are the same as embodiment 9.Effect is with embodiment 9 without significant difference.
Table 11
Claims (10)
1. a kind of composition for providing amino acid, vitamin and mineral, including composition first, composition second and composition
Third;
The composition first is the composition for providing amino acid;The composition first includes following 7 kinds of active ingredient:Hydroxyl dried meat
Propylhomoserin, proline, glutamic acid, Amino Acids in Tea, L-Leu, l-Isoleucine and Valine;Hydroxyproline, proline,
Glutamic acid, Amino Acids in Tea, L-Leu, l-Isoleucine and Valine quality proportioning be followed successively by:0.2-1:0.2-1:
2-5:0.05-0.3:1-3:0.5-1.5:0.5-1.5;
Composition second is vitamin premix;Include following 12 kinds of active ingredient in the composition second:Ingredient I -1, ingredient I -
2, ingredient I -3, ingredient I -4, ingredient I -5, ingredient I -6, ingredient I -7, ingredient I -8, ingredient I -9, ingredient I -10, ingredient I -11 and
Ingredient I -12;Ingredient I -1 provides the substance with vitamin A function, and ingredient I -2 provides the substance with vitamin B1 function,
Ingredient I -3 provides the substance with vitamin B2 function, and ingredient I -4 provides the substance with vitamin B3 function, and ingredient I -5 carries
For the substance with vitamin B5 function, ingredient I -6 provides the substance with vitamin B6 function, and ingredient I -7, which provides, has dimension
The substance of raw element B9 functions, ingredient I -8 provide the substance with vitamin B12 function, and ingredient I -9, which provides, has vitamin C work(
The substance of energy, ingredient I -10 provide the substance with vitamin D function, and ingredient I -11 provides the substance with Function of Vitamin-E,
Ingredient I -12 provides the substance with biotin function;Ingredient I -1, ingredient I -2, ingredient I -3, ingredient I -4, ingredient I -5, at
The proportioning of I -6, ingredient I -7, ingredient I -8, ingredient I -9, ingredient I -10, ingredient I -11 and ingredient I -12 is divided to be followed successively by 1100-
1650μg:14.22-21.33mg:7.112-10.67mg:49.11-73.67mg:17.33-26.00mg:7.112-10.67mg:
888.9-1333μg:14.22-21.33μg:255.5-383.3mg:25.55-38.33μg:49.12-73.68mg:121.12-
181.68μg;
Composition third is mineral substance premix;Include following 9 kinds of active ingredient in the composition third:Ingredient II -1, ingredient II -
2, ingredient II -3, ingredient II -4, ingredient II -5, ingredient II -6, ingredient II -7, ingredient II -8 and ingredient II -9;Ingredient II -1 carries
For sodium element, ingredient II -2 provides P elements, and ingredient II -3 provides potassium element, and ingredient II -4 provides magnesium elements, and ingredient II -5 carries
For calcium constituent, ingredient II -6 provides ferro element, and ingredient II -7 provides Zn-ef ficiency, and ingredient II -8 provides selenium element, and ingredient II -9 carries
For iodine;Sodium element, the P elements by the offer of ingredient II -2, the potassium by the offer of ingredient II -3 provided by ingredient II -1 is first
Element, by ingredient II -4 provide magnesium elements, by ingredient II -5 provide calcium constituent, by ingredient II -6 provide ferro element, by
The proportioning of the Zn-ef ficiency for dividing II -7 offer, the selenium element provided by ingredient II -8 and the iodine provided by ingredient II -9 is followed successively by
85.19-127.8mg:40.92-61.39mg:85.18-127.8mg:13.08-19.61mg:35.19-52.78mg:1.2088-
1.8134mg:1.4226-2.134mg:2.208-3.312μg:3.614-5.420μg.
2. composition as described in claim 1, it is characterised in that:In the composition first, hydroxyproline, proline, paddy ammonia
Acid, theanine, L-Leu, l-Isoleucine and Valine quality proportioning be followed successively by:0.7:0.9g:3.6g:0.07:
2.13:1.12:1.12.
3. composition as claimed in claim 1 or 2, it is characterised in that:The raw material of the composition first includes:Wheat gluten,
Whole milk powder, hydrolyzing lactoalbumin peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid and tealeaves ammonia
Base acid.
4. composition as claimed in claim 3, it is characterised in that:In the raw material of the composition first, wheat gluten, whole milk
Powder, hydrolyzing lactoalbumin peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid and Amino Acids in Tea
Quality proportioning is followed successively by:6.37:4.5:2.15:1.5:1.5:1.43:2.8:0.28.
5. the composition as described in any in Claims 1-4, it is characterised in that:
Ingredient I -1, ingredient I -2, ingredient I -3, ingredient I -4, ingredient I -5, ingredient I -6, ingredient I -7, ingredient I -8, ingredient I -9,
The proportioning of ingredient I -10, ingredient I -11 and ingredient I -12 is followed successively by 1375 μ g:17.78mg:8.89mg:61.39mg:21.67mg:
8.89mg:1111μg:17.78μg:319.4mg:31.94μg:61.4mg:151.4μg;
By ingredient II -1 provide sodium element, by ingredient II -2 provide P elements, by ingredient II -3 provide potassium element, by
The magnesium elements for dividing II -4 offer, the calcium constituent provided by ingredient II -5 are carried by the ferro element of the offer of ingredient II -6, by ingredient II -7
The proportioning of the Zn-ef ficiency of confession, the selenium element provided by ingredient II -8 and the iodine provided by ingredient II -9 is followed successively by 106.5mg:
51.16mg:106.49mg:16.35mg:43.99mg:1.52mg:1.78mg:2.76μg:4.52μg.
6. composition as claimed in claim 5, it is characterised in that:
The vitamin premix is by ingredient I -1, ingredient I -2, ingredient I -3, ingredient I -4, ingredient I -5, ingredient I -6, ingredient I -
7, ingredient I -8, ingredient I -9, ingredient I -10, ingredient I -11, ingredient I -12 and filler composition;
Ingredient I -1, ingredient I -2, ingredient I -3, ingredient I -4, ingredient I -5, ingredient I -6, ingredient I-in per 1g vitamin premixs
7, the content of ingredient I -8, ingredient I -9, ingredient I -10, ingredient I -11 and ingredient I -12 is followed successively by 1100-1650 μ g, 14.22-
21.33mg,7.112-10.67mg,49.11-73.67mg,17.33-26.00mg,7.112-10.67mg,888.9-1333μg,
14.22-21.33μg,255.5-383.3mg,25.55-38.33μg,49.12-73.68mg,121.12-181.68μg;
The mineral substance premix by ingredient II -1, ingredient II -2, ingredient II -3, ingredient II -4, ingredient II -5, ingredient II -6,
Ingredient II -7, ingredient II -8, ingredient II -9 and filler composition;
By the sodium element of the offer of ingredient II -1, the P elements provided by ingredient II -2, by ingredient II-in per 1g mineral substance premixes
3 provide potassium element, by ingredient II -4 provide magnesium elements, by ingredient II -5 provide calcium constituent, by ingredient II -6 provide
Ferro element, the Zn-ef ficiency provided by ingredient II -7, the selenium element provided by ingredient II -8 and the iodine provided by ingredient II -9
Content be followed successively by 85.19-127.8mg, 40.92-61.39mg, 85.18-127.8mg, 13.08-19.61mg, 35.19-
52.78mg,1.2088-1.8134mg,1.4226-2.134mg,2.208-3.312μg,3.614-5.420μg。
7. composition as claimed in claim 6, it is characterised in that:
Ingredient I -1, ingredient I -2, ingredient I -3, ingredient I -4, ingredient I -5, ingredient I -6, ingredient I-in per 1g vitamin premixs
7, the content of ingredient I -8, ingredient I -9, ingredient I -10, ingredient I -11 and ingredient I -12 be followed successively by 1375 μ g, 17.78mg,
8.89mg,61.39mg,21.67mg,8.89mg,1111μg,17.78μg,319.4mg,31.94μg,61.4mg,151.4μg;
By the sodium element of the offer of ingredient II -1, the P elements provided by ingredient II -2, by ingredient II-in per 1g mineral substance premixes
3 provide potassium element, by ingredient II -4 provide magnesium elements, by ingredient II -5 provide calcium constituent, by ingredient II -6 provide
Ferro element, the Zn-ef ficiency provided by ingredient II -7, the selenium element provided by ingredient II -8 and the iodine provided by ingredient II -9
Content be followed successively by 106.5mg, 51.16mg, 106.49mg, 16.35mg, 43.99mg, 1.52mg, 1.78mg, 2.76 μ g,
4.52μg。
8. the composition as described in any in claim 1 to 7, it is characterised in that:
The ingredient I -1 is axerophtholum aceticum, and the ingredient I -2 is thiamine hydrochloride, and the ingredient I -3 is riboflavin, described
Ingredient I -4 is niacinamide, and the ingredient I -5 is D-VB5 calcium, and the ingredient I -6 is puridoxine hydrochloride, and the ingredient I -7 is dimension
Raw element B9, the ingredient I -8 are cyanocobalamin, and the ingredient I -9 is L-AA sodium, and the ingredient I -10 is vitamine D3,
The ingredient I -11 is dl- α-D-α-tocopherol acetate, and the ingredient I -12 is D-Biotin;
The ingredient II -1 is sodium citrate and/or disodium hydrogen phosphate, and the ingredient II -2 is disodium hydrogen phosphate, the ingredient
II -3 is potassium citrate and/or potassium chloride, and the ingredient II -4 is magnesium carbonate, and the ingredient II -5 is calcium carbonate, the ingredient
II -6 is ferric pyrophosphate, and the ingredient II -7 is zinc sulfate, and the ingredient II -8 is sodium selenite, and the ingredient II -9 is acid iodide
Potassium.
9. a kind of product, including product A and product B;
The raw material of product A includes:Wheat gluten, whole milk powder, hydrolyzing lactoalbumin peptide, PURE WHEY, soybean protein isolate
Powder, collagen, branched-chain amino acid, Amino Acids in Tea, crystal diabetin, oligofructose, sodium carboxymethylcellulose, resistant dextrin,
Any minerals are pre- in any vitamin premix and claim 1 to 8 in taurine, claim 1 to 8
Batch mixing;Wheat gluten, whole milk powder, hydrolyzing lactoalbumin peptide, PURE WHEY, soybean separation protein white powder, collagen, branch
Amino acid, Amino Acids in Tea, crystal diabetin, oligofructose, sodium carboxymethylcellulose, resistant dextrin, taurine, vitamin premix
The quality proportioning of material and mineral substance premix is followed successively by 6.37:4.5:2.15:1.5:1.5:1.43:2.8:0.28:5.07:0.9:
0.8:1.72:0.04:0.13:0.81;
The raw material of product B includes:Any institute in any vitamin premix, claim 1 to 8 in claim 1 to 8
The luxuriant Cillium of the mineral substance premix stated, Sucralose, Guarana extract, taurine, circle,Abundant power
Peptide, maltodextrin, polydextrose, DEXTROSE ANHYDROUS, crystal diabetin, isomalt, PURE WHEY, soybean protein isolate
Powder, medium chain fatty acid, strange sub- seed powder, coconut slurry powder and shredded coconut stuffing;Vitamin premix, mineral substance premix, Sucralose, Guarana
The luxuriant Cillium of extract, taurine, circle,Abundant power peptide, maltodextrin, polydextrose, DEXTROSE ANHYDROUS, knot
Brilliant fructose, isomalt, PURE WHEY, soybean separation protein white powder, medium chain fatty acid, strange sub- seed powder, coconut slurry powder and coconut palm
The quality proportioning of Rong is followed successively by:1.2:21:0.03:1.1:1.2:1.6:8.3:12.04:12.5:41.63:24.9:24.9:
20.8:24.9:33.2:8.3:49.9:12.5.
10. the application of product described in any composition or claim 9 in claim 1 to 8, for following (c1) or
(c2):
(c1) motor function beverage is prepared;
(c2) it is used as motor function beverage.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810326525.2A CN108684999A (en) | 2018-04-12 | 2018-04-12 | A kind of motor function beverage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810326525.2A CN108684999A (en) | 2018-04-12 | 2018-04-12 | A kind of motor function beverage |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108684999A true CN108684999A (en) | 2018-10-23 |
Family
ID=63844926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810326525.2A Pending CN108684999A (en) | 2018-04-12 | 2018-04-12 | A kind of motor function beverage |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108684999A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110050855A (en) * | 2019-04-10 | 2019-07-26 | 井冈山大学 | A kind of sports drink of suitable fat body builder |
US20200376091A1 (en) * | 2019-06-03 | 2020-12-03 | Vital Proteins LLC | Recovery dietary supplement |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1399035B1 (en) * | 2001-06-29 | 2004-10-20 | Fundacion Universitat Empresa de les Illes Balears | Isotonic energy drink and procedure for obtaining it |
CN101869295A (en) * | 2010-05-24 | 2010-10-27 | 北京世纪维他生物技术有限公司 | Production method of nutrient premix used for foods |
CN101982121A (en) * | 2010-09-19 | 2011-03-02 | 中国科学院广州生物医药与健康研究院 | Functional sports drink and preparation method thereof |
CN105661235A (en) * | 2016-01-22 | 2016-06-15 | 江苏艾兰得营养品有限公司 | Beverage for supplementing compound nutrients and production method thereof |
CN106387585A (en) * | 2016-08-31 | 2017-02-15 | 宣城柏维力生物工程有限公司 | Taurine electrolyte sports solid beverage and production technology thereof |
CN106617086A (en) * | 2016-12-30 | 2017-05-10 | 贝克尔(天津)药业有限公司 | Nutritional food capable of enhancing exercise capacity and exercise tolerance |
-
2018
- 2018-04-12 CN CN201810326525.2A patent/CN108684999A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1399035B1 (en) * | 2001-06-29 | 2004-10-20 | Fundacion Universitat Empresa de les Illes Balears | Isotonic energy drink and procedure for obtaining it |
CN101869295A (en) * | 2010-05-24 | 2010-10-27 | 北京世纪维他生物技术有限公司 | Production method of nutrient premix used for foods |
CN101982121A (en) * | 2010-09-19 | 2011-03-02 | 中国科学院广州生物医药与健康研究院 | Functional sports drink and preparation method thereof |
CN105661235A (en) * | 2016-01-22 | 2016-06-15 | 江苏艾兰得营养品有限公司 | Beverage for supplementing compound nutrients and production method thereof |
CN106387585A (en) * | 2016-08-31 | 2017-02-15 | 宣城柏维力生物工程有限公司 | Taurine electrolyte sports solid beverage and production technology thereof |
CN106617086A (en) * | 2016-12-30 | 2017-05-10 | 贝克尔(天津)药业有限公司 | Nutritional food capable of enhancing exercise capacity and exercise tolerance |
Non-Patent Citations (9)
Title |
---|
冯炜权等: "《运动生物化学原理》", 31 December 1995, 北京体育大学出版社 * |
吕晓华等: "《合理饮食与健康》", 31 August 2015 * |
姚亮,等: "《天天健康的秘诀》", 31 July 2003, 学林出版社 * |
杨晓萍: "《茶叶营养与功能》", 31 July 2017, 中国轻工业出版社 * |
王尧,等: "《365的健康叮咛》", 28 February 2017, 青岛出版社 * |
王建明: "运动员维生素和矿物质的合理补充", 《冰雪运动》 * |
约翰•怀斯曼: "《怀斯曼体能训练手册》", 30 November 2016, 北方文艺出版社 * |
蔡威: "《食物营养学》", 30 September 2006, 上海交通大学出版社 * |
袁海平: "《运动营养学》", 31 March 2007, 北京体育大学出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110050855A (en) * | 2019-04-10 | 2019-07-26 | 井冈山大学 | A kind of sports drink of suitable fat body builder |
US20200376091A1 (en) * | 2019-06-03 | 2020-12-03 | Vital Proteins LLC | Recovery dietary supplement |
US11666639B2 (en) * | 2019-06-03 | 2023-06-06 | Societe Des Produits Nestle S.A. | Recovery dietary supplement |
EP3976088A4 (en) * | 2019-06-03 | 2023-10-11 | Société des Produits Nestlé S.A. | Recover dietary supplement |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1321589C (en) | Soy-bean peptide | |
Kreider et al. | Effects of ingesting supplements designed to promote lean tissue accretion on body composition during resistance training | |
US6136339A (en) | Food supplements and methods comprising lipoic acid and creatine | |
US20040023889A1 (en) | Alpha lipoic acid based food supplement for increasing lean muscle mass and strength | |
CN1364430A (en) | Method for storaging acid liquid or semiliquid composition containing kreatin for human consumption | |
CN105558744B (en) | A kind of effervescent tablet and preparation method thereof containing branched-chain amino acid | |
KR20020062927A (en) | Food supplement for increasing lean mass and strength | |
CN107772446A (en) | A kind of high-protein nutrient thing combination for Velocity-force class and preparation method thereof | |
CN108552451B (en) | Functional beverage after sports | |
CN108684999A (en) | A kind of motor function beverage | |
CN105495582A (en) | Anti-fatigue and restorative health-care food amino acid composition | |
CN100356876C (en) | Beverage for promoting sportive recovery from fatigue | |
WO2007063297A1 (en) | Improvements in and relating to nutritional products | |
KR20170107471A (en) | Lotion manufacturing products or food supplements | |
CN112841566A (en) | Nutritional seasoning sauce and preparation method thereof | |
US20050042302A1 (en) | Mixture of base-containing micronutrient substances | |
Jordan et al. | Ergogenic aids and the female athlete | |
CN105661222A (en) | Whey protein compound drink suitable for drinking of sports groups | |
CN101331950A (en) | Nutritional supplement for increasing sports break-out force | |
CN109984268A (en) | A kind of calcium supplement for pet vitamin liquid and preparation method thereof | |
CN108669391A (en) | Drinks before a kind of movement | |
AU2021253451A1 (en) | Vitality dietary supplement | |
Sonawane et al. | An Overview on characterization and value addition of traditional Indian fermented food: idli | |
EP2745710A1 (en) | A nutraceutical compound | |
JP2003061631A (en) | Powder beverage and food mainly comprising citric acid and amino acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |